Succinylcholine-induced rhabdomyolysis in a patient with RYR1 and BCHE variants: A case report
Biomolecules and Biomedicine · 10.11.2025 · 26 (5) · 862-868
DOI: 10.17305/bb.2025.13435 ↗Kurz gefasst
Fallbericht in der Zeitschrift Biomolecules and Biomedicine, online erschienen am 10.11.2025. Verfasst von Tracy E Harrison und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Anesthesiology and Perioperative Medicine, Mayo Clinic, Rochester, Minnesota, USA. Hauptthemen laut MEDLINE: Butyrylcholinesterase, Rhabdomyolysis, Ryanodine Receptor Calcium Release Channel, Succinylcholine. Die Arbeit wurde bisher 1-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Masseter muscle spasm after succinylcholine can herald malignant hyperthermia (MH) in genetically susceptible individuals. We aimed to describe the perioperative course and genetic findings in a patient who developed transient masseter spasm and postoperative rhabdomyolysis after general anesthesia. This single-patient case report draws on perioperative observations, laboratory testing, and whole-genome sequencing. Immediately after induction with propofol and succinylcholine, the patient experienced transient masseter spasm; anesthesia was then maintained with total intravenous anesthesia (propofol and remifentanil). Postoperatively, laboratory studies showed severe rhabdomyolysis with mild pigment nephropathy; the patient received intravenous hydration, laboratory values normalized by postoperative day 4, and discharge occurred in good condition. Whole-genome sequencing identified heterozygous ryanodine receptor 1 (RYR1) c.1840C>T (p.Arg614Cys)—a known MH-susceptibility variant in the skeletal-muscle ryanodine receptor—and butyrylcholinesterase (BCHE) c.293A>G (p.Asp98Gly), which reduces butyrylcholinesterase activity and delays succinylcholine hydrolysis. The coexistence of these variants likely synergistically increased sarcoplasmic reticulum Ca²⁺ release and prolonged succinylcholine effect, precipitating rhabdomyolysis; to our knowledge, this appears to be the first reported case linking concurrent RYR1 and BCHE variants to rhabdomyolysis following general anesthesia.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Anesthesiology and Perioperative Medicine, Mayo Clinic, Rochester, Minnesota, USA.
Zitieren
APA
Harrison, T. E., Weingarten, T. N., & Sprung, J. (2025). Succinylcholine-induced rhabdomyolysis in a patient with RYR1 and BCHE variants: A case report. Biomolecules and Biomedicine, 26(5), 862-868. https://doi.org/10.17305/bb.2025.13435
Vancouver
Harrison TE, Weingarten TN, Sprung J. Succinylcholine-induced rhabdomyolysis in a patient with RYR1 and BCHE variants: A case report. Biomolecules and Biomedicine. 2025;26(5):862-868. doi:10.17305/bb.2025.13435
BibTeX
@article{Harrison2025,
author = {Harrison, Tracy E and Weingarten, Toby N and Sprung, Juraj},
title = {Succinylcholine-induced rhabdomyolysis in a patient with RYR1 and BCHE variants: A case report},
journal = {Biomolecules and Biomedicine},
year = {2025},
volume = {26},
number = {5},
pages = {862--868},
doi = {10.17305/bb.2025.13435}
}
EUVIMED